An observational study in High Myopia, Cataract and Visual Outcome, sponsored by Shanghai High Myopia Study Group. Recruiting at 1 site in China. Open to participants aged 20 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-11.
Sponsored by Shanghai High Myopia Study Group · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 184 studies in Cataract with a site in China — 39 open to participants now, 49 under way, none of them phase 3. Cataract · China.
Among the 184 studies in Cataract with a site in China, this one is the 2nd largest by planned enrollment of the 73 observational ones that give a count, is one of 7 that started in 2015, is one of 73 observational ones, reaches primary completion later than 48 of the 48 other live ones, and was the 47th registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →39 of the 184 studies in Cataract with a site in China are open now. Recruiting first, the newest first:
Zhongshan Ophthalmic Center, Sun Yat-sen University · Sites in China
Ages 18–90
Nanfang Hospital, Southern Medical University · Sites in China
Ages 40–85
Second Affiliated Hospital, School of Medicine, Zhejiang University · Sites in China
Ages 18+
Nanfang Hospital, Southern Medical University · Sites in China
Ages 18–90
Zhongshan Ophthalmic Center, Sun Yat-sen University · Sites in China
Ages 50–90
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 20 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
184 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 7 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60,000 is above the median of 90 across 477 observational studies indexed under Cataract.
Median enrollment 90 across the 111 interventional studies, 120 across the 73 observational. Of the 80 that completed or were terminated, 9 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 184 have an industry lead sponsor. The 10 most frequent:
Shanghai High Myopia Study Group is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Shanghai High Myopia Study Group has 3 studies filed under Cataract — fewer than ten, so there is no comparison to draw.
7 of the studies in Cataract with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07713069Zhongshan Ophthalmic Center, Sun Yat-sen UniversityOCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction | 2026-11-30 |
| NCT02182921Evidence Based Cataract Study GroupEvaluation of Cataract Surgery Outcome | 2026-12 |
| NCT07550907Zhongshan Ophthalmic Center, Sun Yat-sen UniversityThe Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors | 2026-12-31 |
| NCT07733154The Hong Kong Polytechnic UniversityAI-Driven IOL Prediction Using SS-OCT Biometry | 2027-03-20 |
| NCT07126470Zhongshan Ophthalmic Center, Sun Yat-sen UniversityImpact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients | 2027-08 |
Add all 7 to your calendar (.ics) → With an account.
Among the 184 studies in Cataract with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract and age-related cataract patients. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of high myopic cataract.
High myopic cataract (HMC) has become a major high-risky type of cataract in China, which accounts for nearly 30% of cataract in recent years. Compared to age-related cataract, HMC is characterized with earlier onset, severer lens opacities, higher incidence of vitreoretinopathy and postoperative complications compared to age-related cataract(ARC).
The main purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract, when compared to those age-matched ARC patients.
On the other hand, due to the lack of research in the pathogenesis of HMC, it is difficult for the investigators to precisely evaluate its risk and prognosis, and to improve its prevention and treatment. The previous study of investigators majored in a large-sample analysis on the clinical features and related genes of HMC. After preliminary screening, eight genes were selected for further investigation: 1) genes related to pathogenesis of HMC: CRYAA/ GSTP1/ TXNRD2;2) genes related to vitreoretinopathy: MCP1/ VEGFA/ CFH; 3) genes related to postoperative complications: TGFB2/ CERS2. In the present study, in order to establish a risk model of HMC from the aspect of precision medicine, the investigators are preparing to set up a comprehensive clinical database for further sequencing of selected genes (including exons, promoters, 5' UTR and 3' UTR sequences) on a large scale, to intensively investigate into the sites and functions of single nucleotide polymorphism (SNP) correlated with clinical features of HMC.
The research aim to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract, to thoroughly illustrate the influence of HMC-related genes to its prognosis and to elucidate the pathogenesis of HMC, for further promotion in the disease prevention and prognosis as well.
Cataract patients who will undergo cataract surgery in Eye and ENT Hospital of Fudan University.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cataract patients with high myopia.
Other: Cataract
Age-related cataract patients.
Other: Cataract
Cataract patients with ametropia.
Other: Cataract
The genetic and environmental factors concerning to the pathogenesis of cataract in the three groups.
Differences in the clinical phenotypes and visual outcomes of high myopic cataract patients
Cataract type and severity of high myopic cataract patients are evaluated using LOCSIII grading system. Visual outcomes are also evaluated including visual acuity with or without correction, intraocular pressure, fundus function, contrast sensitivity and other visual outcome measurements.
Time frame: Follow-up until five years after surgery
Differences in the clinical phenotypes and visual outcomes of age-related cataract patients
Cataract type and severity of age-related cataract patients are evaluated using LOCSIII grading system. Visual outcomes are also evaluated including visual acuity with or without correction, intraocular pressure, fundus function, contrast sensitivity and other visual outcome measurements.
Time frame: Follow-up until five years after surgery
Differences in the clinical phenotypes and visual outcomes of ametropic cataract patients
Cataract type and severity of ametropic cataract patients are evaluated using LOCSIII grading system. Visual outcomes are also evaluated including visual acuity with or without correction, intraocular pressure, fundus function, contrast sensitivity and other visual outcome measurements.
Time frame: Follow-up until five years after surgery
Genetic diversity based on biological specimen samples of three groups
Sequencing of selected genes (including exons, promoters, 5' UTR and 3' UTR sequences) on a large scale to intensively investigate into the sites and functions of single nucleotide polymorphism (SNP) correlated with clinical features of HMC, compared to age-related cataract and ametropic cataract patients.
Time frame: Analyzed within six months after surgery
Difference in the surgical procedure of three groups
To compare the difference in the surgical procedure of three groups.
Time frame: Recorded on the surgery day for further analysis
Difference in the Diagnostic test of three groups
To compare the difference in the diagnostic test of three groups.
Time frame: Recorded before the surgery day for further analysis
Difference in the complications of the cataract surgery of three groups
To compare the prevalence of complications of the cataract surgery in HMC,ARC and ametropic cataract patients.
Time frame: Follow-up until five years after surgery
Plan to share: Undecided — Undecided.
Started Jan 2015 (actual). Primary completion is estimated for Dec 2035, 251 months after the start.
Of 169 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's planned 251 months is above that.
Counting every sponsor, half of 236 studies reached it within 16 months; a quarter within 9 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai High Myopia Study Group